Holstein, K., Quellec, S. L., Klamroth, R., Batorova, A., Holme, P. A., Jiménez Yuste, V. M., & Astermark, J. (2021). Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
Citación estilo ChicagoHolstein, Katharina, Sandra Le Quellec, Robert Klamroth, Angelika Batorova, Pål Andre Holme, Víctor Manuel Jiménez Yuste, y Jan Astermark. Immune Tolerance Induction in the Era of Emicizumab – Still the First Choice for Patients With Haemophilia A and Inhibitors? 2021.
Cita MLAHolstein, Katharina, et al. Immune Tolerance Induction in the Era of Emicizumab – Still the First Choice for Patients With Haemophilia A and Inhibitors? 2021.
Precaución: Estas citas no son 100% exactas.